A host of household names could quit the stock market in a £600billion exodus from London, analysts have warned.
AstraZeneca, Shell, BP and Rio Tinto, are among those seen to be ‘at risk’ of moving their main listings to New York in what would be a devastating blow to the City.
Analysis by broker AJ Bell identified ten London-listed firms that do so much business in the US, or have so many shareholders there, that they may be tempted to make the switch.
The combined value of the firms – which also include Compass, Experian, Bunzl, Smith & Nephew, Rentokil and Fresnillo – is £620billion.
No respite: A host of household names could quit the stock market in a £600billion exodus from London, which would be a blow to Rachel Reeves
‘An onslaught of UK-listed companies upping sticks for the US would be terrible for the reputation of the London market,’ said Dan Coatsworth at AJ Bell.
Miners Glencore and Anglo American, worth a combined £73billion, have ruled out moving to New York. But it is feared an exodus by other top firms could see them change their mind.
CRH, Flutter, Indivior and Ferguson have made the switch while Ashtead and Wise are in the process of moving. Coatsworth said there is a list of UK firms that could ‘make a good argument for switching their main stock listing to the US.’
He added: ‘The more companies that move, the more the topic will be discussed in the boardroom by other companies that have a US presence.’
The latest bout of anxiety about an exodus comes after AstraZeneca last week announced plans for a full listing in New York alongside London – sparking fears it could lead to a permanent move.
DIY INVESTING PLATFORMS
AJ Bell
AJ Bell
Easy investing and ready-made portfolios
Hargreaves Lansdown
Hargreaves Lansdown
Free fund dealing and investment ideas
interactive investor
interactive investor
Flat-fee investing from £4.99 per month
InvestEngine
InvestEngine
Account and trading fee-free ETF investing
Trading 212
Trading 212
Free share dealing and no account fee
Affiliate links: If you take out a product This is Money may earn a commission. These deals are chosen by our editorial team, as we think they are worth highlighting. This does not affect our editorial independence.
